Nagaileben Co (TSE:7447) ROCE % : 8.96% (As of Feb. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Nagaileben Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nagaileben Co's annualized ROCE % for the quarter that ended in Feb. 2024 was 8.96%.

Nagaileben Co ROCE % Historical Data

The historical data trend for Nagaileben Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nagaileben Co ROCE % Chart

Nagaileben Co Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

ROCE %

Get a 7-Day Free Trial

12.28

12.04

12.36

11.65

10.53

Nagaileben Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
ROCE %	Get a 7-Day Free Trial															11.64	15.56	9.68	6.10	8.96

Nagaileben Co ROCE % Calculation

Nagaileben Co's annualized ROCE % for the fiscal year that ended in Aug. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Aug. 2023 )		(A: Aug. 2022 )		(A: Aug. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Aug. 2023 )		(A: Aug. 2022 )		(A: Aug. 2023 )
	=	4604.877	/	( ( (47347.978 - 4048.594)	+	(47377.716 - 3223.537) )	/ 2 )
	=	4604.877	/	( (43299.384	+	44154.179)	/ 2 )
	=	4604.877	/	43726.7815
	=	10.53 %

Nagaileben Co's ROCE % of for the quarter that ended in Feb. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Feb. 2024 )		(Q: Nov. 2023 )		(Q: Feb. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Feb. 2024 )		(Q: Nov. 2023 )		(Q: Feb. 2024 )
	=	3802.728	/	( ( (45001.124 - 2876.26)	+	(45577.812 - 2834.508) )	/ 2 )
	=	3802.728	/	( ( 42124.864	+	42743.304 )	/ 2 )
	=	3802.728	/	42434.084
	=	8.96 %

(1) Note: The EBIT data used here is four times the quarterly (Feb. 2024) EBIT data.

Nagaileben Co (TSE:7447) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nagaileben Co ROCE % Related Terms

Thank you for viewing the detailed overview of Nagaileben Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nagaileben Co (TSE:7447) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Manufacturing - Apparel & Accessories » Nagaileben Co Ltd (TSE:7447) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-2-19 Iwamoto-cho Chiyoda-ku, Tokyo, JPN, 101-0032

Website

http://www.nagaileben.co.jp

Nagaileben Co Ltd manufactures and sells medical clothing and shoes for doctors, dentists, pharmacists, nursing staff, patients, and care workers. Nearly all the company's sales are in Japan, with more than half of total sales in east Japan and the remaining Japanese sales in central Japan and west Japan. The company's six item segments are healthcare wear, surgery wear, doctor wear, utility wear, patient wear, and shoes. Healthcare wear accounts for more than half of total company revenue. Doctors' wear, patient wear, and surgery wear constitute most of the remaining revenue. The company manufactures its products in Japan and Indonesia.

Nagaileben Co (TSE:7447) Headlines

No Headlines